DURVALUMAB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 20 adverse event reports in the FDA FAERS database where DURVALUMAB was used for Prostate cancer.
Most Reported Side Effects for DURVALUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,817 | 16.4% | 2,816 | 98 |
| Malignant neoplasm progression | 1,330 | 7.8% | 343 | 166 |
| Pneumonitis | 827 | 4.8% | 221 | 333 |
| Radiation pneumonitis | 786 | 4.6% | 112 | 343 |
| Pyrexia | 573 | 3.3% | 79 | 372 |
| Diarrhoea | 530 | 3.1% | 99 | 267 |
| Pneumonia | 453 | 2.6% | 169 | 300 |
| Dyspnoea | 444 | 2.6% | 113 | 215 |
| Interstitial lung disease | 430 | 2.5% | 144 | 220 |
| Off label use | 395 | 2.3% | 70 | 102 |
| Fatigue | 367 | 2.1% | 57 | 102 |
| Rash | 359 | 2.1% | 43 | 94 |
| Neutrophil count decreased | 343 | 2.0% | 49 | 76 |
| Asthenia | 326 | 1.9% | 104 | 121 |
| Colitis | 319 | 1.9% | 73 | 164 |
Other Indications for DURVALUMAB
Non-small cell lung cancer (3,396)
Hepatocellular carcinoma (1,255)
Small cell lung cancer (1,063)
Bile duct cancer (972)
Non-small cell lung cancer stage iii (840)
Small cell lung cancer extensive stage (660)
Lung neoplasm malignant (641)
Pancreatic carcinoma (584)
Cholangiocarcinoma (444)
Neoplasm malignant (253)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)